-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QPSJ8Ip+GuXOMLDYExk14tBDrs361i6PvmSIkF/aGqj5VRon4JRZGjjHtRoDUEOL LT3U/FY44s0MobMMso4llw== 0000882377-03-001946.txt : 20031202 0000882377-03-001946.hdr.sgml : 20031202 20031202152115 ACCESSION NUMBER: 0000882377-03-001946 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030930 FILED AS OF DATE: 20031202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CALYPTE BIOMEDICAL CORP CENTRAL INDEX KEY: 0000899426 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 061226727 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1265 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502- BUSINESS PHONE: 5107495100 MAIL ADDRESS: STREET 1: 1265 HARBOR BAY PKWY CITY: ALAMEDA STATE: CA ZIP: 94502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARR TECHNOLOGIES BV CENTRAL INDEX KEY: 0001262853 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-20985 FILM NUMBER: 031032524 BUSINESS ADDRESS: STREET 1: STRAWINSKYLAAN 1431 STREET 2: 1077XX CITY: AMSTERDAM THE NEDTHERLANDS STATE: P7 ZIP: 00000 BUSINESS PHONE: 0110031206625501 MAIL ADDRESS: STREET 1: STRAWINSKYLAAN 1431 STREET 2: 1077XX CITY: AMSTERDAM THE NETHERLANDS STATE: P7 ZIP: 00000 3/A 1 p03-930_ex.xml X0201 3/A 2003-09-30 2003-10-01 0 0000899426 CALYPTE BIOMEDICAL CORP CYPT 0001262853 MARR TECHNOLOGIES BV STRAWINSKYLAAN 1431 1077XX AMSTERDAM THE NEDTHERLANDS P7 00000 NETHERLANDS 0 0 1 0 Common Stock, par value $0.03 per share 38915151 D These shares are owned directly by Marr Technologies BV, which is a wholly owned subsidiary of Marr Technologies NV, which is a wholly owned subsidiary of Marr Technologies Limited, which is a wholly owned subsidiary of Marr Group Holdings Limited, which is controlled by Marat R. Safin. Marr Technologies NV, Marr Technologies Limited, Marr Group Holdings Limited and Marat R. Safin are indirect beneficial owners of the reported securities. Christian Strik 2003-11-28 EX-99 3 d181454.txt JOINT FILER INFORMATION FORM 3 JOINT FILER INFORMATION
Name: Marr Technologies NV Address: Van Engelenweg 21 A Curacao Netherlands Antilles Designated Filer: Marr Technologies BV Issuer & Ticker Symbol: Calypte Biomedical Corporation "CYPT" Date of Event Requiring Statement: 9/30/03 Signature: By: /s/ George Praag --------------------------------------- Name: George Praag Title: Director of C.T.M. Corporation N.V. Name: Marr Technologies Limited Address: Suite 240, Barkly Wharf, Le Caudan Waterfront, Port Louis, Mauritius Designated Filer: Marr Technologies BV Issuer & Ticker Symbol: Calypte Biomedical Corporation "CYPT" Date of Event Requiring Statement: 9/30/03 Signature: By: /s/ Marat R. Safin --------------------------------------- Name: Marat R. Safin Title: Director EXHIBIT 99 FORM 3 JOINT FILER INFORMATION Name: Marr Group Holdings Limited Address: Suite 240, Barkly Wharf, Le Caudan Waterfront, Port Louis, Mauritius Designated Filer: Marr Technologies BV Issuer & Ticker Symbol: Calypte Biomedical Corporation "CYPT" Date of Event Requiring Statement: 9/30/03 Signature: By: /s/ Marat R. Safin --------------------------------------- Name: Marat R. Safin Title: Director Name: Marat R. Safin Address: 46 Clapham Common North Side London SW4 0AA United Kingdom Designated Filer: Marr Technologies BV Issuer & Ticker Symbol: Calypte Biomedical Corporation "CYPT" Date of Event Requiring Statement: 9/30/03 Signature: /s/ Marat R. Safin ----------------------------------------- Name: Marat R. Safin
-----END PRIVACY-ENHANCED MESSAGE-----